Updated Dec 21
Related News
Dec 27, 2025
Ozempic and Zepbound: Romance Woes or Weight-Loss Wonders?
Discover how GLP-1 weight-loss drugs like Ozempic and Zepbound are reshaping romance, with users reporting reduced libido and altered relationships due to appetite suppression. A New York Times podcast shines light on these intimate impacts through a couple's eye-opening journey.
OzempicZepboundGLP-1 drugs
Nov 15, 2025
Trump Administration Strikes Major Deal with Pharma Giants: Ozempic Prices Slashed!
In an unprecedented move, President Trump has announced a landmark deal with Novo Nordisk and Eli Lilly to significantly reduce the prices of popular GLP-1 medications, including Ozempic and Wegovy. These drugs, crucial for diabetes and obesity treatment, will see slashed prices for Medicare, Medicaid, and cash-paying patients, all part of the new TrumpRx initiative aimed at broadening access and alleviating drug costs. The deal reflects a pivotal shift in U.S. healthcare policy with far-reaching implications for patients and the pharmaceutical industry.
TrumpRxGLP-1 medicationsOzempic
Dec 27, 2024
Elon Musk Celebrates the Holidays as ‘Ozempic Santa’, Sparking Weight Loss Conversations!
In a festive twist, Elon Musk revealed he's taking the weight-loss drug Mounjaro while clad in a Santa suit he dubbed 'Ozempic Santa.' This merry disclosure not only played on Ozempic’s catchy name but also kickstarted debates on the rising trend of GLP-1 medications for weight management. As these drugs gain traction, it’s a reminder of the blend of technology, health, and quirky humor Musk often brings to the table.
Elon MuskMounjaroOzempic